SCHEMBL30666248

SCHEMBL30666248

CC(C)(C)OC(=O)N1CCC2(CC1)CC(c1cc3nnc(-c4ccccc4O)cc3s1)C2

nearest known ligand 0.52

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ SMARCA2 P51531 2/20 0.52
▸ SMARCA4 P51532 2/20 0.52
▸ PBRM1 Q86U86 2/20 0.52
▸ SCD5 Q86SK9 1/20 0.40
▸ GPR119 Q8TDV5 7/20 0.39
▸ NAMPT P43490 5/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP11B2 P19099 1/20 0.37
▸ JAK2 O60674 1/20 0.37
▸ JAK1 P23458 1/20 0.37
▸ TERT O14746 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26683210 1.00 SMARCA2 (0.52) SMARCA2SMARCA4PBRM1SCD5GPR119
SCHEMBL27172162 0.86 SMARCA2 (0.52) SMARCA2SMARCA4PBRM1GPR119NAMPT
SCHEMBL26683270 0.82 GPR119 (0.40) SCD5GPR119NAMPTCYP2C9
SCHEMBL30666220 0.82 GPR119 (0.40) SCD5GPR119NAMPTCYP2C9
SCHEMBL26683498 0.78 SMARCA2 (0.52) SMARCA2SMARCA4PBRM1SCD5GPR119
SCHEMBL30666247 0.78 SMARCA2 (0.52) SMARCA2SMARCA4PBRM1SCD5GPR119
SCHEMBL26683624 0.78 PBRM1 (0.41) SMARCA2SMARCA4PBRM1
SCHEMBL30666266 0.78 SMARCA2 (0.48) SMARCA2SMARCA4PBRM1SCD5GPR119
SCHEMBL26683411 0.78 SMARCA2 (0.48) SMARCA2SMARCA4PBRM1SCD5GPR119
SCHEMBL30666234 0.75 SMARCA2 (0.56) SMARCA2SMARCA4PBRM1GPR119NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522277-A1 PYRAZINE DERIVATIVES AND USES THEREOF Foghorn Therapeutics Inc. (US) 2025-03-19 — — EP disclosed
WO-2023220137-A1 PYRAZINE DERIVATIVES AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2023-11-16 — — WO disclosed
Send feedback